<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Introduction • SimTOST</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="Introduction">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body data-spy="scroll" data-target="#toc">


    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">SimTOST</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.3.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles

    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/intropkg.html">Introduction</a>
    </li>
    <li>
      <a href="../articles/sampleSize_crossover.html">Bioequivalence Tests for 2x2 Cross-Over Trial Designs with Log-Normal Data</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_2A1E.html">Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 1 Endpoint</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_2A3E.html">Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 3 Endpoints</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_3A1E.html">Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 1 Endpoint</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_3A3E.html">Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 3 Endpoints</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel.html">Bioequivalence Tests for Parallel Trial Designs with Log-Normal Data</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/" class="external-link">
    <span class="fab fa-github fa-lg"></span>

  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip>Introduction</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/blob/main/vignettes/intropkg.Rmd" class="external-link"><code>vignettes/intropkg.Rmd</code></a></small>
      <div class="hidden name"><code>intropkg.Rmd</code></div>

    </div>

    
    
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://github.com/smartdata-analysis-and-statistics/SimTOST" class="external-link">SimTOST</a></span><span class="op">)</span></span></code></pre></div>
<div class="section level2">
<h2 id="hypotheses">Hypotheses<a class="anchor" aria-label="anchor" href="#hypotheses"></a>
</h2>
<p>The null and alternative hypotheses for the equivalence test are
presented below for two different approaches:</p>
<div class="section level3">
<h3 id="difference-of-means-dom">Difference of Means (DOM)<a class="anchor" aria-label="anchor" href="#difference-of-means-dom"></a>
</h3>
<p>One common approach for assessing bioequivalence involves comparing
pharmacokinetic (PK) measures between test and reference products. This
is done using the following interval (null) hypothesis:</p>
<p>Null Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>):
At least one endpoint does not meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>0</mn></msub><mo>:</mo><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>≤</mo><msub><mi>δ</mi><mi>L</mi></msub><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mtext mathvariant="normal">or</mtext><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>≥</mo><msub><mi>δ</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for at least one</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_0: m_T^{(j)} - m_R^{(j)} \le \delta_L ~~ \text{or}~~ m_T^{(j)} - m_R^{(j)} \ge \delta_U \quad \text{for at least one}\;j</annotation></semantics></math></p>
<p>Alternative Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>1</mn></msub><annotation encoding="application/x-tex">H_1</annotation></semantics></math>):
All endpoints meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>1</mn></msub><mo>:</mo><msub><mi>δ</mi><mi>L</mi></msub><mo>&lt;</mo><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>&lt;</mo><msub><mi>δ</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for all</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_1: \delta_L&lt;m_{T}^{(j)}-m_{R}^{(j)} &lt;\delta_U \quad\text{for all}\;j</annotation></semantics></math></p>
<p>Here,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>m</mi><mi>T</mi></msub><annotation encoding="application/x-tex">m_T</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>m</mi><mi>R</mi></msub><annotation encoding="application/x-tex">m_R</annotation></semantics></math>
represent the mean endpoints for the test product (the proposed
biosimilar) and the reference product, respectively. The equivalence
limits,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>δ</mi><mi>L</mi></msub><annotation encoding="application/x-tex">\delta_L</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>δ</mi><mi>u</mi></msub><annotation encoding="application/x-tex">\delta_u</annotation></semantics></math>,
are typically chosen to be symmetric, such that
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>δ</mi><mo>=</mo><mo>−</mo><msub><mi>δ</mi><mi>L</mi></msub><mo>=</mo><msub><mi>δ</mi><mi>U</mi></msub></mrow><annotation encoding="application/x-tex">\delta = - \delta_L = \delta_U</annotation></semantics></math>.</p>
<p>The null hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>)
is rejected if, and only if, all null hypotheses associated with the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>K</mi><annotation encoding="application/x-tex">K</annotation></semantics></math>
primary endpoints are rejected at a significance level of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>α</mi><annotation encoding="application/x-tex">\alpha</annotation></semantics></math>.
This ensures that equivalence is established across all endpoints
simultaneously.</p>
<p>The DOM test can be implemented in <a href="../reference/sampleSize.html">sampleSize()</a> by setting
<code>ctype = "DOM"</code> and <code>lognorm = FALSE</code>.</p>
<p>For pharmacokinetic (PK) outcomes, such as the area under the curve
(AUC) and maximum concentration (Cmax), log-transformation is commonly
applied to achieve normality. To perform this transformation, the
logarithm of the geometric mean should be provided to
<code>mu_list</code>, while the logarithmic variance can be derived from
the coefficient of variation (CV) using the formula:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext mathvariant="normal">Logarithmic Variance</mtext><mo>=</mo><mo>log</mo><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>+</mo><msup><mtext mathvariant="normal">CV</mtext><mn>2</mn></msup><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">
\text{Logarithmic Variance} = \log\left(1 + {\text{CV}^2}\right)
</annotation></semantics></math></p>
<p>Equivalence limits must also be specified on the log scale to align
with the transformed data.</p>
</div>
<div class="section level3">
<h3 id="ratio-of-means-rom">Ratio of Means (ROM)<a class="anchor" aria-label="anchor" href="#ratio-of-means-rom"></a>
</h3>
<p>The equivalence hypotheses can also be expressed as a Ratio of Means
(ROM):</p>
<p>Null Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>):
At least one endpoint does not meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>0</mn></msub><mo>:</mo><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>≤</mo><msub><mi>E</mi><mi>L</mi></msub><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mtext mathvariant="normal">or</mtext><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>≥</mo><msub><mi>E</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for at least one</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_0: \frac{\mu_T^{(j)}}{\mu_R^{(j)}} \le E_L ~~ \text{or}~~ \frac{\mu_T^{(j)}}{\mu_R^{(j)}} \ge E_U \quad \text{for at least one}\;j</annotation></semantics></math></p>
<p>Alternative Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>1</mn></msub><annotation encoding="application/x-tex">H_1</annotation></semantics></math>):
All endpoints meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>1</mn></msub><mo>:</mo><msub><mi>E</mi><mi>L</mi></msub><mo>&lt;</mo><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>&lt;</mo><msub><mi>E</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for all</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_1: E_L&lt; \frac{\mu_{T}^{(j)}}{\mu_{R}^{(j)}} &lt; E_U \quad\text{for all}\;j</annotation></semantics></math></p>
<p>Here,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>μ</mi><mi>T</mi></msub><annotation encoding="application/x-tex">\mu_T</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>μ</mi><mi>R</mi></msub><annotation encoding="application/x-tex">\mu_R</annotation></semantics></math>
represent the arithmetic mean endpoints for the test product (the
proposed biosimilar) and the reference product, respectively.</p>
<p>The ROM test can be implemented in <a href="../reference/sampleSize.html">sampleSize()</a> by setting
<code>ctype = "ROM"</code> and <code>lognorm = TRUE</code>. Note that
the <code>mu_list</code> argument should contain the arithmetic means of
the endpoints, while <code>sigma_list</code> should contain their
corresponding variances.</p>
<p>The ROM test is converted to a Difference of Means (DOM) tests by
log-transforming the data and equivalence limits. The variance on the
log scale is calculated using the normalized variance formula:</p>
<p><span class="math display">$$
\text{Logarithmic Variance} = \log\left(1 + \text{Arithmetic
Variance}}{\text{Arithmetic Mean}^2}\right)
$$</span></p>
<p>The logarithmic mean is then calculated as:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext mathvariant="normal">Logarithmic Mean</mtext><mo>=</mo><mo>log</mo><mrow><mo stretchy="true" form="prefix">(</mo><mtext mathvariant="normal">Arithmetic Mean</mtext><mo stretchy="true" form="postfix">)</mo></mrow><mo>−</mo><mfrac><mn>1</mn><mn>2</mn></mfrac><mrow><mo stretchy="true" form="prefix">(</mo><mtext mathvariant="normal">Logarithmic Variance</mtext><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">\text{Logarithmic Mean} = \log(\text{Arithmetic Mean}) - \frac{1}{2}(\text{Logarithmic Variance})</annotation></semantics></math></p>
</div>
<div class="section level3">
<h3 id="regulatory-requirements">Regulatory Requirements<a class="anchor" aria-label="anchor" href="#regulatory-requirements"></a>
</h3>
<p>When evaluating bioequivalence, certain statistical and
methodological requirements must be adhered to, as outlined in the
European Medicines Agency’s bioequivalence guidelines <span class="citation">(<a href="#ref-CHMP2010">Committee for Medicinal
Products for Human Use (CHMP) 2010</a>)</span>. These requirements
ensure that the test and reference products meet predefined criteria for
equivalence in terms of PK parameters. The key considerations are
summarized below:</p>
<ul>
<li>Hypothesis testing should be based on the ratio of the population
geometric means</li>
<li>The 90% confidence interval for the ratio of the test and reference
products should be contained within the acceptance interval of 80.00 to
125.00%.</li>
<li>A margin of clinical equivalence
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>Δ</mi><annotation encoding="application/x-tex">\Delta</annotation></semantics></math>)
is chosen by defining the largest difference that is clinically
acceptable, so that a difference larger than this would matter in
practice.</li>
<li>The data should be transformed prior to analysis using a logarithmic
transformation and subsequently be analyzed using ANOVA</li>
</ul>
<p>When conducting a DOM test, The FDA recommends that the equivalence
acceptance criterion (EAC) be defined as
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>δ</mi><mo>=</mo><mi>E</mi><mi>A</mi><mi>C</mi><mo>=</mo><mn>1.5</mn><msub><mi>σ</mi><mi>R</mi></msub></mrow><annotation encoding="application/x-tex">\delta = EAC = 1.5 \sigma_R</annotation></semantics></math>,
where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>σ</mi><mi>R</mi></msub><annotation encoding="application/x-tex">\sigma_R</annotation></semantics></math>
represents the variability of the log-transformed endpoint for the
reference product.</p>
</div>
</div>
<div class="section level2">
<h2 id="testing-of-multiple-endpoints">Testing of multiple endpoints<a class="anchor" aria-label="anchor" href="#testing-of-multiple-endpoints"></a>
</h2>
<p>Assessment of equivalence is often required for more than one primary
variable. <span class="citation">(<a href="#ref-sozu_sample_2015">Sozu
et al. 2015</a>)</span> For example, EMA recommends showing equivalence
both for AUC and Cmax</p>
<p>A decision must be made as to whether it is desirable to</p>
<ul>
<li>Demonstrate equivalence for all primary endpoints
<ul>
<li>This is the most common setting and is often referred to as having
<em>multiple co-primary endpoints</em>.</li>
<li>Equivalence must be demonstrated for <strong>all</strong> endpoints
to conclude overall equivalence.</li>
</ul>
</li>
<li>Demonstrate equivalence for at least one of the primary endpoints
<ul>
<li>Known as having <em>multiple primary endpoints</em>.</li>
<li>Equivalence is required for <strong>at least one</strong> endpoint
to meet the study’s objectives.</li>
</ul>
</li>
</ul>
<div class="section level3">
<h3 id="testing-multiple-co-primary-endpoints">Testing multiple co-primary endpoints<a class="anchor" aria-label="anchor" href="#testing-multiple-co-primary-endpoints"></a>
</h3>
<p>If the aim of a trial is to evaluate joint effects across all
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
co-primary endpoints <span class="citation">(<a href="#ref-sozu_sample_2015">Sozu et al. 2015</a>)</span>, a
multiplicity adjustment is not required to control the Type I error
rate, as all null hypotheses must be rejected to establish equivalence.
However, as the number of endpoints
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>K</mi><annotation encoding="application/x-tex">K</annotation></semantics></math>)
increases, the Type II error rate also increases. <span class="citation">(<a href="#ref-mielke_sample_2018">Mielke et al.
2018</a>)</span> This leads to the following implications:</p>
<ul>
<li>The power to detect equivalence decreases for a fixed sample
size.</li>
<li>The probability of trial success is reduced as more endpoints are
evaluated simultaneously.</li>
</ul>
<p>Previous studies have demonstrated that the sample size required to
achieve a given power level increases as the number of endpoints
increases <span class="citation">(<a href="#ref-mielke_sample_2018">Mielke et al. 2018</a>)</span>. This
increase in sample size can be substantial, particularly when there is
no correlation between the test statistics and/or when a large number of
tests are conducted. The impact of the number of endpoints on the
required sample size is less pronounced when the correlation between
endpoints is high.</p>
<p>One possible solution, if the required sample size is not feasible,
is to power the study so that at least
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>k</mi><annotation encoding="application/x-tex">k</annotation></semantics></math>
out of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
tests have to meet the equivalence criterion.</p>
</div>
<div class="section level3">
<h3 id="testing-multiple-primary-endpoints">Testing multiple primary endpoints<a class="anchor" aria-label="anchor" href="#testing-multiple-primary-endpoints"></a>
</h3>
<p>When a trial aims to evaluate equivalence for at least
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>k</mi><annotation encoding="application/x-tex">k</annotation></semantics></math>
out of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
primary endpoints, adjustment for the increased probability of a Type I
error due to multiple hypothesis testing is required. For example, with
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>m</mi><mo>=</mo><mn>3</mn></mrow><annotation encoding="application/x-tex">m=3</annotation></semantics></math>
independent primary endpoints and a significance level of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>α</mi><mo>=</mo><mn>5</mn><mi>%</mi></mrow><annotation encoding="application/x-tex">\alpha = 5\%</annotation></semantics></math>,
the probability of making a Type I error on at least one hypothesis test
is:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi>–</mi><msup><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>−</mo><mi>α</mi><mo stretchy="true" form="postfix">)</mo></mrow><mi>m</mi></msup><mo>=</mo><mn>1</mn><mo>−</mo><msup><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>−</mo><mn>0.05</mn><mo stretchy="true" form="postfix">)</mo></mrow><mn>3</mn></msup><mo>=</mo><mn>0.1426</mn><mi>.</mi></mrow><annotation encoding="application/x-tex"> 1 – (1-\alpha)^m  = 1 - (1-0.05)^3 = 0.1426. </annotation></semantics></math>
This means that the overall probability of making any false positive
error, also known as the <strong>family-wise error rate (FWER)</strong>,
increases to approximately 14%.</p>
<p>To address this issue, adjustments to the significance level are
necessary for multiple endpoint comparisons for which various methods
have been proposed. In SimTOST, the following approaches are
included:</p>
<div class="section level4">
<h4 id="bonferroni-correction">Bonferroni correction<a class="anchor" aria-label="anchor" href="#bonferroni-correction"></a>
</h4>
<p>The most common and easiest procedure for multiplicity adjustment to
control the FWER is the Bonferroni method. Each hypothesis is tested at
level</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>α</mi><mrow><mi>b</mi><mi>o</mi><mi>n</mi></mrow></msub><mo>=</mo><mi>α</mi><mi>/</mi><mi>m</mi></mrow><annotation encoding="application/x-tex">\alpha_{bon}= \alpha/m</annotation></semantics></math></p>
<p>where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
is the total number of tests. Although simple, this method is highly
conservative, particularly when tests are correlated, as it assumes all
tests are independent. This conservativeness remains pronounced even for
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>k</mi><mo>=</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">k=1</annotation></semantics></math>,
where only one of the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
hypotheses needs to be rejected. <span class="citation">(<a href="#ref-mielke_sample_2018">Mielke et al. 2018</a>)</span></p>
<p>In the <a href="../reference/sampleSize.html">sampleSize()</a>
function, the Bonferroni correction can be applied by setting
<code>adjust = "bon"</code>.</p>
</div>
<div class="section level4">
<h4 id="sidak-correction">Sidak correction<a class="anchor" aria-label="anchor" href="#sidak-correction"></a>
</h4>
<p>The Sidak correction is an alternative method for controlling the
FWER. Like the Bonferroni correction, it assumes that tests are
independent. However, the Sidak correction accounts for the joint
probability of all tests being non-significant, making it mathematically
less conservative than the Bonferroni method. The adjusted significance
level is calculated as:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>α</mi><mrow><mi>s</mi><mi>i</mi><mi>d</mi></mrow></msub><mo>=</mo><mn>1</mn><mo>−</mo><msup><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>−</mo><mi>α</mi><mo stretchy="true" form="postfix">)</mo></mrow><mrow><mn>1</mn><mi>/</mi><mi>m</mi></mrow></msup></mrow><annotation encoding="application/x-tex">\alpha_{sid}= 1-(1-\alpha)^ {1/m}</annotation></semantics></math></p>
<p>The Sidak correction can be implemented by specifying
<code>adjust = "sid"</code> in the <a href="../reference/sampleSize.html">sampleSize()</a> function.</p>
</div>
<div class="section level4">
<h4 id="k-adjustment">K adjustment<a class="anchor" aria-label="anchor" href="#k-adjustment"></a>
</h4>
<p>This correction explicitly accounts for the scenario where
equivalence is required for only
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>k</mi><annotation encoding="application/x-tex">k</annotation></semantics></math>
out of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
endpoints. Unlike the Bonferroni and Sidak corrections, which assume
that all
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
tests contribute equally to the overall Type I error rate, the
<em>k</em>-adjustment directly incorporates the number of endpoints
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>k</mi><annotation encoding="application/x-tex">k</annotation></semantics></math>)
required for equivalence into the adjustment. The adjusted significance
level is calculated as:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>α</mi><mi>k</mi></msub><mo>=</mo><mfrac><mrow><mi>k</mi><mo>*</mo><mi>α</mi></mrow><mi>m</mi></mfrac></mrow><annotation encoding="application/x-tex">\alpha_k= \frac{k*\alpha}{m}</annotation></semantics></math></p>
<p>where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>k</mi><annotation encoding="application/x-tex">k</annotation></semantics></math>
is the number of endpoints required for equivalence, and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
is the total number of endpoints evaluated.</p>
</div>
<div class="section level4">
<h4 id="sequential-adjustment">Sequential adjustment<a class="anchor" aria-label="anchor" href="#sequential-adjustment"></a>
</h4>
<p>In this approach, the user specifies which endpoints are primary and
which are secondary using the <code>type_y</code> vector parameter.
Tests are then performed sequentially, starting with the primary
endpoints. If the tests on the primary endpoints are accepted, the
procedure proceeds with testing of the secondary endpoints.</p>
<p>The significance level
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>α</mi><annotation encoding="application/x-tex">\alpha</annotation></semantics></math>)
is adjusted separately for each group of endpoints:</p>
<ul>
<li>
<strong>Primary Endpoints</strong>: A Bonferroni adjustment is
applied based on the number of primary endpoints.</li>
<li>
<strong>Secondary Endpoints</strong>: If the primary endpoints meet
the equivalence criteria, the secondary endpoints are tested. These are
also adjusted using the Bonferroni method, based on the number of
secondary endpoints.</li>
</ul>
<p>Sequential adjustment ensures that the Type I error is controlled
while prioritizing the evaluation of primary endpoints before moving on
to secondary ones.</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="testing-of-multiple-treatments">Testing of multiple treatments<a class="anchor" aria-label="anchor" href="#testing-of-multiple-treatments"></a>
</h2>
<p>In certain cases, it may be necessary to compare multiple treatments
simultaneously. This can be achieved by specifying multiple comparators
in the <code>mu_list</code> and <code>sigma_list</code> parameters. The
<a href="../reference/sampleSize.html">sampleSize()</a> function can
accommodate multiple treatments, allowing for the evaluation of
equivalence across different products or formulations.</p>
<p>Although trials with multiple arms are common, there is no clear
consensus in the literature as to whether statistical corrections should
be applied for testing multiple primary hypotheses in such analyses. In
SimTOST, no adjustments are made for trials involving more than two
treatment arms.</p>
</div>
<div class="section level2">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-CHMP2010" class="csl-entry">
Committee for Medicinal Products for Human Use (CHMP). 2010.
<span>“Guideline on the Investigation of Bioequivalence.”</span>
CPMP/EWP/QWP/1401/98. London, UK: European Medicines Agency. <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf" class="external-link">https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf</a>.
</div>
<div id="ref-mielke_sample_2018" class="csl-entry">
Mielke, Johanna, Byron Jones, Bernd Jilma, and Franz König. 2018.
<span>“Sample <span>Size</span> for <span>Multiple Hypothesis
Testing</span> in <span>Biosimilar Development</span>.”</span>
<em>Statistics in Biopharmaceutical Research</em> 10 (1): 39–49. <a href="https://doi.org/10.1080/19466315.2017.1371071" class="external-link">https://doi.org/10.1080/19466315.2017.1371071</a>.
</div>
<div id="ref-sozu_sample_2015" class="csl-entry">
Sozu, Takashi, Tomoyuki Sugimoto, Toshimitsu Hamasaki, and Scott R.
Evans. 2015. <em>Sample <span>Size Determination</span> in
<span>Clinical Trials</span> with <span>Multiple Endpoints</span></em>.
<span>SpringerBriefs</span> in <span>Statistics</span>. Cham: Springer
International Publishing. <a href="https://doi.org/10.1007/978-3-319-22005-5" class="external-link">https://doi.org/10.1007/978-3-319-22005-5</a>.
</div>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

      </div>

</div>



      <footer><div class="copyright">
  <p></p>
<p>Developed by Thomas Debray, Johanna Muñoz, Dewi Amaliah, Biogen Inc.</p>
</div>

<div class="pkgdown">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

      </footer>
</div>






  </body>
</html>
